Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion.
about
Severe infectious diseases of childhood as monogenic inborn errors of immunityMendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunityA novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon.Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease.Natural variation in immune responses to neonatal Mycobacterium bovis Bacillus Calmette-Guerin (BCG) Vaccination in a Cohort of Gambian infants.Selective inhibition of IFNG-induced autophagy by Mir155- and Mir31-responsive WNT5A and SHH signalingFrom mouth to macrophage: mechanisms of innate immune subversion by Mycobacterium avium subsp. paratuberculosis.Differential combination of cytokine and interferon- γ +874 T/A polymorphisms determines disease severity in pulmonary tuberculosis.Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood.Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways.IFNs and STATs in innate immunity to microorganisms.Community-acquired poliovirus infection in children with primary immunodeficiencies in Tunisia.Jaks, STATs, Cytokines, and Sepsis.Partial recessive IFN-γR1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds.Susceptibility to mycobacterial infections: the importance of host genetics.Inherited and acquired immunodeficiencies underlying tuberculosis in childhood.High-throughput transcriptomics reveals common and strain-specific responses of human macrophages to infection with Mycobacterium abscessus Smooth and Rough variants.STIM1 controls T cell-mediated immune regulation and inflammation in chronic infection.Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis.STAT2 Is a Pervasive Cytokine Regulator due to Its Inhibition of STAT1 in Multiple Signaling PathwaysCD8- DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPSBacteria and mucosal inflammation of the gut: lessons from Helicobacter pylori.Nontuberculous mycobacterial osteomyelitis.Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease.Effect of maternal immune status on responsiveness of bacillus calmette-gurin vaccination in mouse neonates.No association of IFNG+874T/A SNP and NOS2A-954G/C SNP variants with nitric oxide radical serum levels or susceptibility to tuberculosis in a Brazilian population subsetPartial IFN-γR2 deficiency is due to protein misfolding and can be rescued by inhibitors of glycosylation.Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds.Severe Disseminated Mycobacterium avium Infection in a Patient with a Positive Serum Autoantibody to Interferon-γ.Advances and challenges in studying hepatitis C virus in its native environment.Peptide Arrays for Kinome Analysis of Livestock Species.Association of Interferon-γ Receptor-1 Gene Polymorphism with Nontuberculous Mycobacterial Lung Infection among Iranian Patients with Pulmonary Disease.Bioengineered Colorectal Cancer Drugs: Orally Delivered Anti-Inflammatory Agents.Association of Genetic Polymorphisms of IFNGR1 with the Risk of Pulmonary Tuberculosis in Zahedan, Southeast Iran.Genomewide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection.STAT1-dependent IgG cell-surface expression in a human B cell line derived from a STAT1-deficient patient.Helicobacter pylori disrupts STAT1-mediated gamma interferon-induced signal transduction in epithelial cells.The epidemiological feedbacks critical to the evolution of host immunity.Mycobacterium avium subsp. paratuberculosis inhibits gamma interferon-induced signaling in bovine monocytes: insights into the cellular mechanisms of Johne's disease.Infliximab partially impairs the anti-Mycobacterium tuberculosis immune responses of severe psoriasis patients with positive tuberculin skin-test.
P2860
Q26775891-BB52DD1B-D194-4896-A6A9-719904B7FBEFQ26862947-71DA88A4-2B6A-407D-BF53-061B840431CEQ30492620-C907DEA0-16D7-4F7E-8398-EEC0EBBE3279Q33255341-AC423D7D-F3A2-43D8-94CB-D104E2871260Q33378483-2AE1AD12-55C5-4667-B230-67D3C04908F1Q33577564-CEBD0D32-CCC7-467B-BE07-C4EB3D7A5099Q33712909-8044DB85-06FA-4DC1-9E1C-E006611382D7Q34091062-241229D0-E3E8-49F3-AB23-DBCB08F37865Q34290095-A554091F-936A-4407-814A-F9C44DFBFCEFQ34647002-FB87CE08-9A66-48D2-92CF-A24E7E102745Q34647015-2D749EFE-A917-4C5C-B8ED-7F325AB3EDB1Q34772540-B98C8417-BA94-4FBC-B631-1336CA842ABDQ34987949-4717E6A0-C276-475C-ABC4-CA6D7F33B8FFQ35046817-7DF3C3F3-F7CE-4402-BF41-F717C104D46AQ35069566-0FAEDCDF-B82B-4478-818F-993485D0EC27Q35510477-CD2725A3-C214-427D-ADCE-A1A645C8402DQ35865474-CAEE1513-71F1-43EE-95C7-5A2AFECA5748Q35899422-D7546848-33B0-416D-92D9-F45163237F84Q36019386-A1A60342-C5D1-4DC8-AD21-9F8B51935CD5Q36174010-5F4B48D3-FBAC-4E07-859E-FE7534DE15C4Q36229524-F5DDDB37-5F76-4A1A-A62B-FE0CF2116DF1Q36264969-38F1095A-95F3-4739-BBF0-5B606D874F72Q36465965-730F5D4C-34CF-469F-9D53-FF1D67600F09Q36560000-AF9BA555-C2F7-49D5-A466-8121FCADBE78Q37105797-C9EF231C-FB6D-4D24-A3E0-B4F0C0A466B8Q37137632-A6406BE4-AE88-4492-9242-F5B477F366E2Q37215141-5EC13D0D-653D-452A-96BB-A7AC29306AC4Q37360655-C6857D18-7A02-4F7B-9586-865D7843A5CBQ37414412-110B442A-1C3E-477A-9232-45B5B3FF7A61Q37798816-19FFD74B-EBB2-4F9B-B2A2-5C54EEF4E3B9Q38668711-CEF50F22-9FFE-487E-B349-7BA495A0EE4CQ38673928-7FCB8476-D022-4564-9029-739566E171DCQ38879552-09B81980-24AB-47A5-B7CA-3F85358BE27AQ39289313-1353802D-FD32-4311-9361-F980F9A5A3F6Q39523884-019B26BC-C39B-4E5B-9491-0238406123CCQ39732610-C5A1A826-A43A-4EE2-9CE1-0ACE20A9858EQ40582731-C24CB628-53D6-4C0C-BDB3-4AF951561523Q41045621-C3F91420-058A-4BF6-A468-73F595801854Q42275433-559F2A85-9FE4-4779-A4CB-99CAAF1F1063Q45942161-60E68D34-C526-4442-90F8-9799B8DBA6F9
P2860
Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Human interferon-gamma-mediate ...... ome of mycobacterial invasion.
@ast
Human interferon-gamma-mediate ...... ome of mycobacterial invasion.
@en
Human interferon-gamma-mediate ...... ome of mycobacterial invasion.
@nl
type
label
Human interferon-gamma-mediate ...... ome of mycobacterial invasion.
@ast
Human interferon-gamma-mediate ...... ome of mycobacterial invasion.
@en
Human interferon-gamma-mediate ...... ome of mycobacterial invasion.
@nl
prefLabel
Human interferon-gamma-mediate ...... ome of mycobacterial invasion.
@ast
Human interferon-gamma-mediate ...... ome of mycobacterial invasion.
@en
Human interferon-gamma-mediate ...... ome of mycobacterial invasion.
@nl
P2093
P1476
Human interferon-gamma-mediate ...... ome of mycobacterial invasion.
@en
P2093
Casanova JL
Döffinger R
P304
P356
10.1034/J.1600-065X.2000.17810.X
P577
2000-12-01T00:00:00Z